» Articles » PMID: 35872632

The Emergent Role of Mitochondrial RNA Modifications in Metabolic Alterations

Overview
Publisher Wiley
Date 2022 Jul 25
PMID 35872632
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial epitranscriptomics refers to the modifications occurring in all the different RNA types of mitochondria. Although the number of mitochondrial RNA modifications is less than those in cytoplasm, substantial evidence indicates that they play a critical role in accurate protein synthesis. Recent evidence supported those modifications in mitochondrial RNAs also have crucial implications in mitochondrial-related diseases. In the light of current knowledge about the involvement, the association between mitochondrial RNA modifications and diseases arises from studies focusing on mutations in both mitochondrial and nuclear DNA genes encoding enzymes involved in such modifications. Here, we review the current evidence available for mitochondrial RNA modifications and their role in metabolic disorders, and we also explore the possibility of using them as promising targets for prevention and early detection. Finally, we discuss future directions of mitochondrial epitranscriptomics in these metabolic alterations, and how these RNA modifications may offer a new diagnostic and theragnostic avenue for preventive purposes. This article is categorized under: RNA Processing > RNA Editing and Modification.

Citing Articles

Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications.

Li P, Fang X, Huang D Eur J Med Res. 2025; 30(1):98.

PMID: 39940056 PMC: 11823136. DOI: 10.1186/s40001-025-02353-5.


Multi-omic and machine learning analysis of mitochondrial RNA modification genes in lung adenocarcinoma for prognostic and therapeutic implications.

Zhang X, Liu J, Cao Y, Wang W, Lin H, Yu Y Transl Oncol. 2025; 53:102306.

PMID: 39908965 PMC: 11847145. DOI: 10.1016/j.tranon.2025.102306.


Mitochondria: the epigenetic regulators of ovarian aging and longevity.

Mani S, Srivastava V, Shandilya C, Kaushik A, Singh K Front Endocrinol (Lausanne). 2024; 15:1424826.

PMID: 39605943 PMC: 11598335. DOI: 10.3389/fendo.2024.1424826.


RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for degradation and cytosolic release.

Kim S, Tan S, Ku J, Widowati T, Ku D, Lee K Mol Cell. 2024; 84(15):2935-2948.e7.

PMID: 39019044 PMC: 11316625. DOI: 10.1016/j.molcel.2024.06.023.


Mitochondrial RNA modification-based signature to predict prognosis of lower grade glioma: a multi-omics exploration and verification study.

Zhou X, Ling Y, Cui J, Wang X, Long N, Teng W Sci Rep. 2024; 14(1):12602.

PMID: 38824202 PMC: 11144219. DOI: 10.1038/s41598-024-63592-w.